Enliven Therapeutics, Inc. (ELVN)

38.83 +1.04 (+2.75%) USD  |  NASDAQ  |  Apr 02, 16:00
38.72 -0.11 (-0.28%) After-Hours: 20:00
More

Enliven Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ELVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Coherus Oncology, Inc. Upgrade
Kodiak Sciences, Inc. Upgrade
Allogene Therapeutics, Inc. Upgrade